DNA test for spotting endometrial cancer risk
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether a DNA-based cervical smear can find endometrial cancer early in women at higher risk. It looks at women scheduled for a hysteroscopy or receiving hormone therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have medium-to-high risk for endometrial cancer based on Chinese guidelines or are being treated with hormones for a uterine lesion.
- You have not had chemotherapy for your uterine condition.
- You are willing to have at least one follow-up visit within one year.
- You still have your cervix (having had a LEEP or cone biopsy is okay).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new DNA-based method to screen for cervical cancer using a sample of cells from the cervix. It aims to find cancer earlier and more accurately than current methods.
This study tests if a DNA test in urine and vaginal samples you collect at home can help find endometrial cancer. It compares results from people with the cancer to healthy volunteers.
This study uses two simple tests (a cell sample from the uterus and a cervical DNA test) to find endometrial cancer early and to check how well fertility-sparing treatment is working.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This trial tests whether DNA changes in urine, vaginal, or cervical samples can help find endometrial cancer earlier in women with postmenopausal bleeding. If you are having tests for this bleeding, your samples could help improve detection.
This study looks at DNA methylation (a chemical change in your DNA) in women with abnormal HPV or Pap test results to see if it can help predict who might develop cervical cancer. It may help guide future screening and prevention.
Hear when a new Endometrial Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.